In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Zimmer Biomet Holdings (ZBH – Research Report), with a price ...

Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...

“From our first game at RFK, to Ryan Zimmerman’s walk-off to open Nationals Park, and of course [the] 2019 World Series, the last 20 years have been filled with so many amazing and memorable ...

BTIG analyst Ryan Zimmerman maintained a Hold rating on Hologic (HOLX – Research Report) yesterday. The company’s shares closed yesterday at ...

Ryan Zimmerman is an analyst at BTIG. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth ...

This story was excerpted from the Nationals Beat newsletter, with MLB.com reporter Bill Ladson filling in for beat reporter Jessica Camerato this week. To read the full newsletter, click here. And ...